Ben L. Da - Gilead Sci Inc | 人才画像

P134 Efficacy and safety of 48-week off-therapy of Bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta final results from the phase 2b, open-label, randomised, multicentre study MYR204 (2024)

Cited0Views0Bibtex

FRI-371 Undetectable HDV RNA at 24 Weeks of Treatment with Combination Therapy is an Important Predictor of Maintained Response Off-Therapy

Fabien Zoulim,Vladimir Chulanov,Pietro Lampertico,Heiner Wedemeyer, Adrian Streinu‐Cercel,Victor Pântea,Ştefan Lazăr,George Sebastian Gherlan,Pavel Bogomolov,Tatyana Stepanova,Viacheslav Morozov,V. Е. Syutkin,Olga Sagalova,Dmitry Manuilov,Renée-Claude Mercier,Lei Ye,Grace M. Chee,Ben L. Da,Audrey H. Lau, Anu Osinusi,Marc Bourlière, Vlad Ratziu,Stanislas Pol, Marie‐Noëlle Hilleret,Tarik Asselah

Journal of hepatology (2024): S764-S764

Cited0Views0Bibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn